Jeffrey Dayno
Chief Executive Officer chez HARMONY BIOSCIENCES HOLDINGS, INC.
Fortune : - $ au 31/03/2024
Profil
Jeffrey M.
Dayno is the founder of Delaware Valley Stroke Council.
He is currently the President, Chief Executive Officer & Director at Harmony Biosciences Holdings, Inc. since 2023.
He is also currently a Director at Atrin Pharmaceuticals LLC and Emalex Biosciences, Inc. In the past, Dr. Dayno worked as the Senior Director-Medical Services at Merck & Co., Inc. He was also the Medical Director at Jefferson Health Systems Stroke Center Network and the Vice President-Medical Services at Cephalon, Inc. From 2011 to 2014, he served as the Vice President-Global Medical Affairs at Shire ViroPharma, Inc. and from 2010 to 2011, he was the Chief Medical Officer at Labopharm, Inc. He also held the position of Chief Medical Officer at Zyla Life Sciences LLC from 2014 to 2017.
Additionally, he was the President of Labopharm USA, Inc. and served as the Vice President-Global Medical Affairs at Viropharma, Inc. from 2011 to 2014.
Dr. Dayno completed his undergraduate degree at Trinity College (Connecticut) and obtained his doctorate degree from Temple University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeffrey Dayno
| Sociétés | Poste | Début |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Chief Executive Officer | 06/01/2023 |
Atrin Pharmaceuticals LLC
 Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | 16/11/2016 |
Emalex Biosciences, Inc.
 Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emalex Biosciences, Inc. is a biopharmaceutical company. It focuses on the new and novel treatments for patients with central nervous system disorders. The company was founded by Jeffrey S. Aronin and is headquartered in Chicago, IL. | Director/Board Member | - |
Anciens postes connus de Jeffrey Dayno
| Sociétés | Poste | Fin |
|---|---|---|
| ZYLA LIFE SCIENCES | Chief Tech/Sci/R&D Officer | 01/10/2017 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Chief Tech/Sci/R&D Officer | 01/05/2014 |
| Viropharma, Inc. | Corporate Officer/Principal | 01/01/2014 |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Chief Tech/Sci/R&D Officer | 01/07/2011 |
| Delaware Valley Stroke Council | Founder | - |
Formation de Jeffrey Dayno
| Trinity College (Connecticut) | Undergraduate Degree |
| Temple University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
| Labopharm USA, Inc. | |
| Jefferson Health Systems Stroke Center Network | |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
Emalex Biosciences, Inc.
Emalex Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emalex Biosciences, Inc. is a biopharmaceutical company. It focuses on the new and novel treatments for patients with central nervous system disorders. The company was founded by Jeffrey S. Aronin and is headquartered in Chicago, IL. | Health Technology |
| Delaware Valley Stroke Council | |
| Viropharma, Inc. |
